Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-008215
Filing Date
2011-11-08
Accepted
2011-11-08 15:57:40
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT gfr_10q-093011.htm 10-Q 804848
2 EXHIBIT 10.1 ex10-1.htm EX-10.1 37662
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 16834
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 16916
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 5517
6 EXHIBIT 32.2 ex32-2.htm EX-32.2 5582
  Complete submission text file 0001437749-11-008215.txt   3418411

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT gfrpob-20110930.xml EX-101.INS 607866
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gfrpob-20110930.xsd EX-101.SCH 18023
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gfrpob-20110930_cal.xml EX-101.CAL 26937
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gfrpob-20110930_def.xml EX-101.DEF 82118
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gfrpob-20110930_lab.xml EX-101.LAB 117936
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gfrpob-20110930_pre.xml EX-101.PRE 95353
Mailing Address 9160 E. DEER TRAIL 9160 E. DEER TRAIL TUCSAN AZ 85710
Business Address SUITE 11405 - 201A STREET MAPLE RIDGE A1 V2X 0Y3 5205771516
GFR PHARMACEUTICALS INC (Filer) CIK: 0001096294 (see all company filings)

EIN.: 770517964 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27959 | Film No.: 111187766
SIC: 2834 Pharmaceutical Preparations